Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1235 |
|
| Actual shortage: | 56 (5%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1142 (92%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
7 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-TADALAFIL | 5MG | TABLET | Resolved | 2019-01-16 | 2020-06-03 | 72645 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2022-08-15 | 2022-12-01 | 166794 |
| PMS-TADALAFIL | 2.5MG | TABLET | Resolved | 2023-06-09 | 2023-08-07 | 194515 |
| PMS-TADALAFIL | 5MG | TABLET | Actual shortage | 2024-02-07 | 2024-03-15 | 218779 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2024-02-07 | 2024-04-12 | 218782 |
| PMS-TERAZOSIN | 10MG | TABLET | Resolved | 2017-12-08 | 2018-04-19 | 32151 |
| PMS-TERAZOSIN | 1MG | TABLET | Resolved | 2017-12-08 | 2018-04-19 | 32154 |
| PMS-TERAZOSIN | 2MG | TABLET | Resolved | 2017-12-08 | 2018-05-01 | 32157 |
| PMS-TERAZOSIN | 5MG | TABLET | Resolved | 2017-12-08 | 2018-04-19 | 32160 |
| PMS-TERAZOSIN | 10MG | TABLET | Resolved | 2018-06-06 | 2018-10-04 | 51734 |
| PMS-TERAZOSIN | 1MG | TABLET | Resolved | 2018-06-29 | 2018-10-03 | 53269 |
| PMS-TERAZOSIN | 5MG | TABLET | Resolved | 2018-06-29 | 2018-10-03 | 53272 |
| PMS-TERAZOSIN | 2MG | TABLET | Resolved | 2018-07-13 | 2018-11-29 | 55744 |
| PMS-TERAZOSIN | 5MG | TABLET | Resolved | 2022-09-06 | 2022-09-30 | 168634 |
| PMS-TERAZOSIN | 10MG | TABLET | Resolved | 2022-09-06 | 2022-10-27 | 168637 |
| PMS-TERBINAFINE | 250MG | TABLET | Resolved | 2018-11-29 | 2019-03-28 | 67975 |
| PMS-TERBINAFINE | 250MG | TABLET | Resolved | 2018-11-29 | 2019-05-09 | 67978 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Resolved | 2017-12-08 | 2018-04-19 | 32163 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Resolved | 2018-10-19 | 2019-01-17 | 64843 |
| PMS-TESTOSTERONE | 40MG | CAPSULE | Resolved | 2019-03-04 | 2019-06-28 | 77513 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |